核医学在儿童肿瘤中的应用:现状与诊疗一体化聚焦
本文综述核医学在儿童肿瘤管理中的作用,按儿童肿瘤发病率顺序介绍各肿瘤及现有管理路径,再聚焦核医学的角色,最后简述诊疗一体化相关进展。文中指出全球PET-CT装机量增长、核医学常规检查被更多国际指南纳入、特异性放射性药物发展推动精准个体化治疗。
要点
- 核医学在儿童肿瘤管理中作用日益增加,PET-CT装机量全球增长。
- 综述按儿童肿瘤发病率顺序组织,先述各肿瘤管理路径再聚焦核医学角色。
- 文末简述诊疗一体化相关发展前景。
核心结论
- 核医学在儿童肿瘤管理中的作用日益增加,并涉及诊疗一体化发展。
研究设计与样本
- 综述类文章,按儿童肿瘤发病率顺序覆盖各肿瘤及现有管理路径后聚焦核医学角色。
主要发现
- 全球PET-CT装机量增加、核医学常规检查被更多国际指南纳入、特异性放射性药物发展推动精准个体化治疗。
临床怎么用
- 传统核医学专家对儿童肿瘤认识和知识可能有限,本文提供各肿瘤要点及管理路径以供参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Worldwide, Nuclear Medicine is seeing a phenomenal growth in terms of an increasing number of PET-CT scanners being installed, incorporation of routine nuclear medicine procedures in more internationally accepted guidelines as well as advances in the development of more specific radiopharmaceuticals to enable precision guided individualised therapies. In this review, we focus on the increasing role for Nuclear Medicine in the management of paediatric cancers. Since traditional nuclear medicine specialists may have limited awareness and knowledge of paediatric cancers, we have covered this complex topic in the order of frequency of incidence and have provided brief salient points about each cancer and existing management pathways before focusing on the role of Nuclear Medicine. In the final section, we briefly cover some Theranostics related developments on the horizon.
引用
- Pant V, Malasani V, Dash S, et al. Nuclear medicine in paediatric tumours: current status and focus on theranostics. Semin Nucl Med. 2026. PMID: 42493312. doi:10.1053/j.semnuclmed.2026.07.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。